Mª Teresa Velázquez Martín

Dr. Mª Teresa Velázquez Martín

Working Group on Pulmonary Circulation of the ESC
+1
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in The American Journal of Cardiology
Verified
Journal Article
Closed access
PDPablo Diez-Villanueva
Pablo Diez-Villanueva
MGMarcos Manuel García-Guimaraes
Marcos Manuel García-Guimaraes
FMFernando Macaya
Fernando Macaya
MMMónica Masotti
Mónica Masotti
JNJuan Manuel Nogales
Juan Manuel Nogales
FAFernando Alfonso
Fernando Alfonso

1 February 2019 in The American Journal of Cardiology
Verified
Journal Article
Closed access
Jorge NucheJorge Nuche
Jorge Nuche
JCJosé-Manuel Montero Cabezas
José-Manuel Montero Cabezas
CLCarmen Jimenez Lopez-Guarch
Carmen Jimenez Lopez-Guarch
MMMª Teresa Velázquez Martín
Mª Teresa Velázquez Martín
SCSergio Alonso Charterina
Sergio Alonso Charterina
PEP. Escribano-Subias
P. Escribano-Subias

1 March 2019 in Revista Española de Cardiología (English Edition)
Verified
Journal Article
Closed access
MMMª Teresa Velázquez Martín
Mª Teresa Velázquez Martín
AAAgustín Albarrán
Agustín Albarrán
IHIgnacio Hernández
Ignacio Hernández
MLM. Jesús López-Gude
M. Jesús López-Gude
FSFernando Sarnago
Fernando Sarnago
PEPilar Escribano
Pilar Escribano

19 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ACAlejandro Cruz-Utrilla
Alejandro Cruz-Utrilla
MCMaría José Cristo-Ropero
María José Cristo-Ropero
MCMiguel Calderón-Flores
Miguel Calderón-Flores
MMMª Teresa Velázquez Martín
Mª Teresa Velázquez Martín
MLMaría Jesús López-Gude
María Jesús López-Gude
PEP. Escribano-Subias
P. Escribano-Subias
(1) Background: Clinical presentation, disease distribution, or treatment received may provide insights into the reasons contributing to sex differences in chronic thromboembolic pulmonary hypertension (CTEPH). (2) Methods: We evaluated 453 patients (56% women) between 2007–2019. Data was collected from REHAP (Registro Español de Hipertensión Arterial Pulmonar) registry. Two time periods were selected to evaluate the influence of new treatments over time. (3) Results: Women were older. Baseline functional class was worse, and distance walked shorter in women compared with men. Women had higher pulmonary vascular resistances. Despite this, pulmonary endarterectomy (PEA) was carried out in more men, and women received more frequently pulmonary vasodilators exclusively. The 2014–2019 interval was associated with a better survival only among women. Interestingly, women had a more distal disease during this second period of time. (4) Conclusions: Even though women were older, and received invasive treatments less frequently, mortality was similar in both sexes. The introduction of balloon pulmonary angioplasty and the improvement of pulmonary endarterectomy, especially during the last years, could be associated with a survival benefit among women.

1 June 2015 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
MMMª Teresa Velázquez Martín
Mª Teresa Velázquez Martín
AGAgustín Albarrán González-Trevilla
Agustín Albarrán González-Trevilla
SCSergio Alonso Charterina
Sergio Alonso Charterina
JTJulio García Tejada
Julio García Tejada
JRJosé M. Cortina Romero
José M. Cortina Romero
PSPilar Escribano Subías
Pilar Escribano Subías